Search details
1.
RP-3500: A Novel, Potent, and Selective ATR Inhibitor that is Effective in Preclinical Models as a Monotherapy and in Combination with PARP Inhibitors.
Mol Cancer Ther
; 21(2): 245-256, 2022 02.
Article
in English
| MEDLINE | ID: mdl-34911817
Results
1 -
1
de 1
1
Next >
>>